Micrometastatic Disease and Isolated Tumor Cells as a Predictor for Additional Breast Cancer Axillary Metastatic Burden
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Our study aims were to investigate breast cancer patients with micrometastases or isolated tumor cells (ITCs) in sentinel lymph nodes (SLNs) to determine the rate of non-SLN metastasis and axillary recurrences, and to compare actual non-SLN metastasis rates with those predicted by the Memorial Sloan-Kettering Cancer Center (MSKCC) nomogram.
We identified 116 stage I to III breast cancer patients who underwent sentinel lymph node biopsy and had micrometastases or ITCs (<2-mm deposits). Patients underwent completion axillary lymph node dissection (ALND) (group 1) or had no further axillary surgery (group 2). P < 0.05 was considered statistically significant.
Of 116 patients with micrometastases or ITCs in SLNs, 55 (47%) underwent completion ALND (group 1), and 61 (53%) had no further axillary surgery (group 2). The rate of non-SLN metastases in group 1 patients was 9 (16%) of 55, which was significantly less than that predicted by the MSKCC nomogram (median 30%, P < 0.001). Patient age, race, tumor histology, tumor grade, estrogen receptor/Her-2neu status, and lymphovascular invasion did not differ significantly between group 1 patients with positive non-SLNs and those with negative non-SLNs (P > 0.05 for each), but patients with positive non-SLNs had larger tumors (P < 0.001). No patient in group 1 experienced an axillary recurrence, while only one patient (1.6%) in group 2 experienced axillary recurrence.
The actual rate of positive non-SLNs for breast cancer patients with SLN micrometastases or ITCs who underwent completion ALND was significantly less than that predicted by the MSKCC nomogram. The rate of axillary recurrence is negligible, regardless of the extent of axillary staging.
- Green FL, Page DL, Fleming ID, et al., eds. (2002) AJCC cancer staging manual. 6th ed. Chicago: American Joint Commission on Cancer.
- Cote, RJ, Peterson, HF, Chaiwun, B (1999) Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 354: pp. 896-900 CrossRef
- Cox, CE, Kiluk, VJ, Riker, AI (2008) Significance of sentinel lymph node micrometastases in human breast cancer. J Am Coll Surg 206: pp. 261-268 CrossRef
- International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet. 1990;335:1565–8.
- Reed, J, Rosman, M, Verbanac, KM (2009) Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center sentinel node multicenter study. J Am Coll Surg 208: pp. 333-340 CrossRef
- Boer, M, Deurzen, C, Dijck, J (2009) Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 361: pp. 653-663 CrossRef
- Truong, PT, Vinh-Hung, V, Cserni, G (2008) The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer. Eur J Cancer 44: pp. 1670-1677 CrossRef
- Colleoni, M, Rotmensz, N, Peruzzotti, G (2005) Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol 23: pp. 1379-1389 CrossRef
- Kahn, HJ, Hanna, WM, Chapman, JA (2006) Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system. Breast J 12: pp. 294-301 CrossRef
- Fournier, K, Schiller, A, Perry, RR, Laronga, C (2004) Micrometastasis in sentinel lymph nodes of breast cancer does not mandate completion axillary dissection. Ann Surg 239: pp. 859-863 CrossRef
- Lyman, GH, Giuliano, AE, Somerfield, MR (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23: pp. 7703-7720 CrossRef
- Cserni, G, Gregori, D, Merletti, F (2004) Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 91: pp. 1245-1252 CrossRef
- Zee, KJ, Manasseh, DME, Bevilacqua, JLB (2003) A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10: pp. 1140-1151 CrossRef
- Asad, J, Jacobson, AF, Estabrook, A (2008) Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer?. Am J Surg 196: pp. 527-529 CrossRef
- Knauer, M, Mook, S, Rutgers, E (2010) The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer. Breast Cancer Res Treat 120: pp. 655-661 CrossRef
- Vijver, MJ, He, YD, van’t Veer, LJ (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: pp. 1999-2009 CrossRef
- Alran, S, Rycke, Y, Fourchotte, V (2007) Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol 14: pp. 2195-2201 CrossRef
- Menes, TS, Tartter, PI, Mizrachi, H (2005) Breast cancer patients with pN0(i+) and pN1(mi) sentinel nodes have high rate of nonsentinel node metastases. J Am Coll Surg 200: pp. 323-327 CrossRef
- Rijk, MC, Peterse, JL, Nieweg, OE (2006) Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes. Cancer 107: pp. 467-471 CrossRef
- Hwang, RF, Gonzalez-Angulo, AN, Yi, M (2007) Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer 110: pp. 723-730 CrossRef
- Fant, JS, Grant, MD, Knox, SM (2003) Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol 10: pp. 126-130 CrossRef
- Jeruss, JS, Sener, SF, Brinkmann, EM (2005) Axillary recurrence after sentinel node biopsy. Ann Surg Oncol 12: pp. 34-40 CrossRef
- Naik, AM, Fey, JV, Gemignani, M (2004) The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection. Ann Surg 240: pp. 462-471 CrossRef
- Sosa, JA, Diener-West, M, Gusez, Y (1998) Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer. Ann Surg Oncol 5: pp. 140-149 CrossRef
- Hayward, J, Caleffi, M (1987) The significance of local control in the primary treatment of breast cancer. Arch Surg 122: pp. 1244-1247
- Grube, BJ, Giuliano, AE (2001) Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol 20: pp. 230-237 CrossRef
- Micrometastatic Disease and Isolated Tumor Cells as a Predictor for Additional Breast Cancer Axillary Metastatic Burden
Annals of Surgical Oncology
Volume 17, Issue 3 Supplement, pp 303-311
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA
- 2. Department of Surgery, John Cochran Veterans Hospital, St. Louis, MO, USA
- 3. Division of Biostatistics, Washington University School of Medicine, St. Louis, MO, USA